Table 2.

Underlying diseases of study participants

Disease	Count	Total (N = 149,471)
		N	%
Liver diseasea	0	148,632	99.44
	1	354	0.24
	2	475	0.32
	3	10	0.01
Cancerb	0	147,260	98.52
	1	594	0.4
	2	1423	0.95
	3	187	0.13
	4	5	0.00
	5	2	0.00
Diabetes mellitus	0	139,063	93.04
	1	10,408	6.96
Cardio-cerebrovascular diseasec	0	127,608	85.37
	1	2165	1.45
	2	18,719	12.52
	3	825	0.55
	4	139	0.09
	5	15	0.01
Renal diseased	0	148,698	99.48
	1	758	0.51
	2	15	0.01
Degenerative diseasee	0	146,945	98.31
	1	2331	1.56
	2	193	0.13
	3	2	0.00
Lung diseasef	0	147,253	98.52
	1	2086	1.40
	2	122	0.08
	3	10	0.01

^aLiver disease includes hepatitis B, cirrhosis, and any other hepatitis

^bCancer includes liver cancer, thyroid cancer, oral cancer, acute myelogenous white blood, ovarian cancer, brain cancer, colon cancer, lymphoma, chronic myelogenous white blood, bladder cancer, esophageal cancer, cancer, stomach cancer, cervical cancer, uterine cancer, prostate cancer, rectal cancer, skin cancer, hematoma, laryngeal cancer, prostate cancer, hematologic cancer, hematoma, and blood cancer

^cCardio-cerebrovascular disease includes hypertension, stroke, cerebral infarction, myocardial infarction, myocardial hemorrhage, arteriosclerosis, and angina

^dRenal disease includes renal failure, renal failure, and glomerular disease

^eDegenerative diseases include Alzheimer disease, other dementia, and Parkinson disease

^fLung disease includes emphysema and any other lung disease